Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
Nature Medicine|December 24, 2002
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysWolfgang W Leitner, Leroy N Hwang, Michael J deVeer, et al.
The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
The Journal of Clinical Investigation|June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cellsLuca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One|May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingYun Ji, Natalie Abrams, Wei Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccineSteven A Rosenberg, James C Yang, Udai S Kammula, et al.
Journal of Visualized Experiments : Jove|August 27, 2019
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic EmigrantsRaul Vizcardo, S M Rafiqul Islam, Takuya Maeda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinaseTimothy L Frankel, William R Burns, Peter D Peng, et al.
JCI Insight|April 20, 2018
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine modelBenjamin Y Jin, Tracy E Campbell, Lindsey M Draper, et al.
Stem Cell Research & Therapy|November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiationSelami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Blood|September 19, 2008
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersAndrea Boni, Pawel Muranski, Lydie Cassard, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
Nature Medicine|December 24, 2002
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysWolfgang W Leitner, Leroy N Hwang, Michael J deVeer, et al.
The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
The Journal of Clinical Investigation|June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cellsLuca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One|May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingYun Ji, Natalie Abrams, Wei Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccineSteven A Rosenberg, James C Yang, Udai S Kammula, et al.
Journal of Visualized Experiments : Jove|August 27, 2019
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic EmigrantsRaul Vizcardo, S M Rafiqul Islam, Takuya Maeda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinaseTimothy L Frankel, William R Burns, Peter D Peng, et al.
JCI Insight|April 20, 2018
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine modelBenjamin Y Jin, Tracy E Campbell, Lindsey M Draper, et al.
Stem Cell Research & Therapy|November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiationSelami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Blood|September 19, 2008
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersAndrea Boni, Pawel Muranski, Lydie Cassard, et al.
Pageof 26